fr
Article scientifique
Accès libre
Anglais

Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study

Date de publication2021
Résumé

Serological assays detecting anti-SARS-CoV-2 antibodies are being widely deployed in studies and clinical practice. However, the duration and effectiveness of the protection conferred by the immune response remains to be assessed in population-based samples. To estimate the incidence of newly acquired SARS-CoV-2 infections in seropositive individuals as compared to seronegative controls we conducted a retrospective longitudinal matched study.

Mots-clés
  • SARS-CoV-2
  • Reinfection
  • COVID-19
  • Antibody
  • Protection
Citation (format ISO)
LEIDI, Antonio Siro Gabriele et al. Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study. In: Clinical Infectious Diseases, 2021. doi: 10.1093/cid/ciab495
Fichiers principaux (2)
Article (Accepted version)
accessLevelPublic
Article (Published version)
accessLevelRestricted
Fichiers secondaires (1)
Identifiants
ISSN du journal1058-4838
285vues
99téléchargements

Informations techniques

Création31/05/2021 14:37:00
Première validation31/05/2021 14:37:00
Heure de mise à jour16/03/2023 02:06:38
Changement de statut16/03/2023 02:06:35
Dernière indexation17/01/2024 15:33:03
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack